clro-20230331.htm
0000840715 CLEARONE INC Non-accelerated Filer --12-31 false Q1 2023 DE 1 23,955,767 326 1 0000840715 2022-01-01 2022-03-31 0000840715 2021-12-31 0000840715 2023-03-31 0000840715 us-gaap:WarrantMember us-gaap:CommonStockMember 2019-12-17 0000840715 us-gaap:ConvertibleDebtMember us-gaap:CommonStockMember srt:MaximumMember 2019-12-17 2019-12-17 0000840715 us-gaap:ConvertibleDebtMember us-gaap:CommonStockMember 2019-12-17 2019-12-17 0000840715 us-gaap:ConvertiblesAndBondsWithWarrantsAttachedMember 2023-01-01 2023-03-31 0000840715 us-gaap:ConvertibleDebtMember 2019-12-17 2019-12-17 0000840715 us-gaap:ConvertiblesAndBondsWithWarrantsAttachedMember 2019-12-17 2019-12-17 0000840715 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000840715 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0000840715 us-gaap:ConvertibleDebtMember us-gaap:CommonStockMember 2019-12-17 0000840715 us-gaap:ConvertibleDebtMember srt:MaximumMember 2019-12-17 2019-12-17 0000840715 us-gaap:CommonStockMember us-gaap:BeneficialOwnerMember 2019-12-17 2019-12-17 0000840715 us-gaap:ConvertiblesAndBondsWithWarrantsAttachedMember us-gaap:CommonStockMember 2019-12-17 0000840715 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000840715 clro:EuropeAndAfricaMember 2023-01-01 2023-03-31 0000840715 clro:AsiaMiddleEastIndiaAndAustraliaMember 2023-01-01 2023-03-31 0000840715 srt:AmericasMember 2023-01-01 2023-03-31 0000840715 clro:VideoProductsMember 2023-01-01 2023-03-31 0000840715 clro:MicrophonesMember 2023-01-01 2023-03-31 0000840715 clro:AudioConferencingMember 2023-01-01 2023-03-31 0000840715 srt:MaximumMember us-gaap:OtherIntangibleAssetsMember 2023-01-01 2023-03-31 0000840715 srt:MinimumMember us-gaap:OtherIntangibleAssetsMember 2023-01-01 2023-03-31 0000840715 srt:MaximumMember clro:ProprietarySoftwareMember 2023-01-01 2023-03-31 0000840715 srt:MinimumMember clro:ProprietarySoftwareMember 2023-01-01 2023-03-31 0000840715 srt:MaximumMember us-gaap:TradeNamesMember 2023-01-01 2023-03-31 0000840715 srt:MinimumMember us-gaap:TradeNamesMember 2023-01-01 2023-03-31 0000840715 clro:PatentsAndTechnologicalKnowHowMember srt:MinimumMember 2023-01-01 2023-03-31 0000840715 clro:PatentsAndTechnologicalKnowHowMember srt:MaximumMember 2023-01-01 2023-03-31 0000840715 us-gaap:TradeNamesMember 2023-03-31 0000840715 clro:PatentsAndTechnologicalKnowHowMember 2023-03-31 0000840715 clro:ProprietarySoftwareMember 2023-03-31 0000840715 us-gaap:OtherIntangibleAssetsMember 2023-03-31 0000840715 stpr:FL srt:IndustrialPropertyMember 2023-03-31 0000840715 srt:OfficeBuildingMember stpr:UT 2023-03-31 0000840715 country:IN srt:OfficeBuildingMember 2023-03-31 0000840715 stpr:UT srt:WarehouseMember 2023-03-31 0000840715 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-03-31 0000840715 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0000840715 us-gaap:RetainedEarningsMember 2023-03-31 0000840715 us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-03-31 0000840715 us-gaap:MeasurementInputExpectedTermMember 2023-03-31 0000840715 us-gaap:MeasurementInputPriceVolatilityMember 2023-03-31 0000840715 us-gaap:MeasurementInputExpectedDividendRateMember 2023-03-31 0000840715 us-gaap:ConvertibleNotesPayableMember 2023-03-31 0000840715 us-gaap:MajorityShareholderMember us-gaap:BridgeLoanMember us-gaap:NotesPayableOtherPayablesMember 2021-07-02 0000840715 us-gaap:BridgeLoanMember 2021-07-01 2021-07-02 0000840715 us-gaap:MajorityShareholderMember us-gaap:BridgeLoanMember us-gaap:NotesPayableOtherPayablesMember 2021-07-01 2021-07-02 0000840715 us-gaap:CommonStockMember 2021-09-12 0000840715 us-gaap:CommonStockMember 2021-09-12 2021-09-12 0000840715 2023-01-01 2023-03-31 0000840715 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2021-12-31 0000840715 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000840715 us-gaap:RetainedEarningsMember 2021-12-31 0000840715 us-gaap:MajorityShareholderMember us-gaap:BridgeLoanMember 2022-01-04 0000840715 us-gaap:MajorityShareholderMember us-gaap:BridgeLoanMember 2022-01-04 2022-01-04 0000840715 us-gaap:CommonStockMember 2023-03-31 0000840715 clro:AudioConferencingMember 2022-01-01 2022-03-31 0000840715 clro:MicrophonesMember 2022-01-01 2022-03-31 0000840715 clro:VideoProductsMember 2022-01-01 2022-03-31 0000840715 srt:AmericasMember 2022-01-01 2022-03-31 0000840715 clro:AsiaMiddleEastIndiaAndAustraliaMember 2022-01-01 2022-03-31 0000840715 clro:EuropeAndAfricaMember 2022-01-01 2022-03-31 0000840715 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2022-03-31 0000840715 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0000840715 us-gaap:RetainedEarningsMember 2022-03-31 0000840715 us-gaap:ConvertiblesAndBondsWithWarrantsAttachedMember 2022-01-01 2022-03-31 0000840715 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0000840715 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0000840715 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0000840715 clro:SecuritiesPurchaseAgreementMember us-gaap:MajorityShareholderMember us-gaap:PrivatePlacementMember us-gaap:CommonStockMember 2022-01-04 0000840715 2022-12-31 0000840715 2022-03-31 0000840715 us-gaap:TradeNamesMember 2022-12-31 0000840715 clro:PatentsAndTechnologicalKnowHowMember 2022-12-31 0000840715 clro:ProprietarySoftwareMember 2022-12-31 0000840715 us-gaap:OtherIntangibleAssetsMember 2022-12-31 0000840715 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2022-12-31 0000840715 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000840715 us-gaap:RetainedEarningsMember 2022-12-31 0000840715 us-gaap:ConvertibleNotesPayableMember 2022-12-31 0000840715 2023-05-12 0000840715 us-gaap:SubsequentEventMember us-gaap:CommonStockMember us-gaap:DividendDeclaredMember 2023-05-08 2023-05-08 0000840715 us-gaap:SubsequentEventMember us-gaap:CommonStockMember us-gaap:DividendDeclaredMember 2023-05-08 0000840715 us-gaap:MajorityShareholderMember us-gaap:BridgeLoanMember us-gaap:NotesPayableOtherPayablesMember 2022-10-28 2022-10-28 0000840715 us-gaap:MajorityShareholderMember us-gaap:BridgeLoanMember us-gaap:NotesPayableOtherPayablesMember 2022-10-28 0000840715 us-gaap:SubsequentEventMember 2023-04-01 2023-04-30 0000840715 us-gaap:MajorityShareholderMember us-gaap:BridgeLoanMember us-gaap:NotesPayableOtherPayablesMember 2022-12-31 0000840715 us-gaap:MajorityShareholderMember us-gaap:BridgeLoanMember us-gaap:NotesPayableOtherPayablesMember 2023-01-01 2023-01-31 xbrli:shares xbrli:pure utr:D utr:sqft iso4217:USD iso4217:USD xbrli:shares

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

Form 10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2023

 

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period _______ to _______

 

Commission file number:001-33660

CLEARONE, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

87-0398877

(State or other jurisdiction of incorporation or organization)

 

(I.R.S. employer identification number)

 

 

 

5225 Wiley Post Way, Suite 500, Salt Lake City, Utah

 

84116

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (801) 975-7200

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading Symbol(s)

  

Name of each exchange on which registered

Common Stock, $0.001

 

CLRO

 

The NASDAQ Capital Market

 

Indicate by check whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  No 

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Larger Accelerated Filer

Accelerated Filer  

Non-Accelerated Filer

Smaller Reporting Company

 

Emerging Growth Company  


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Yes No


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

 

The number of shares of ClearOne common stock outstanding as of May 12, 2023 was 23,955,767


 CLEARONE, INC.

QUARTERLY REPORT ON FORM 10-Q FOR THE QUARTER ENDED MARCH 31, 2023

 

INDEX




PART I - FINANCIAL INFORMATION



Item 1. Financial Statements 3




Unaudited Condensed Consolidated Balance Sheets as of March 31, 2023 and December 31, 2022 3




Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss for the three months ended March 31, 2023 and 2022 4




Unaudited Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2023 and 2022 5




Unaudited Notes to Condensed Consolidated Financial Statements 7



Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 17



Item 3. Quantitative and Qualitative Disclosures About Market Risk 23



Item 4. Controls and Procedures 23




PART II - OTHER INFORMATION



Item 1. Legal Proceedings 24



Item 1A. Risk Factors 24



Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 24



Item 3. Defaults Upon Senior Securities 24



Item 4. Mine Safety Disclosures 24



Item 5. Other Information 24



Item 6. Exhibits 25

 

 

 

 

 

CLEARONE, INC

(Dollars in thousands, except par value)

 

 

 

March 31, 2023

 

 

December 31, 2022

 

ASSETS

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

59,006

 

 

$

984

 

Legal settlement receivable




55,000

Receivables, net of allowance of $326

 

 

3,541

 

 

 

3,603

 

Inventories, net

 

 

8,395

 

 

 

8,961

 

Income tax receivable




1,071

Prepaid expenses and other assets

 

 

3,635

 

 

 

7,808

 

Total current assets

 

 

74,577

 

 

 

77,427

 

Long-term inventories, net

 

 

2,885

 

 

 

2,707

 

Property and equipment, net

 

 

356

 

 

 

383

 

Operating lease - right of use assets, net

 

 

1,259

 

 

 

1,047

 

Intangibles, net

 

 

1,995

 

 

 

2,071

 

Other assets

 

 

112

 

 

 

115

 

Total assets

 

$

81,184

 

 

$

83,750

 

LIABILITIES AND SHAREHOLDERS' EQUITY

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

1,820

 

 

$

1,284

 

Accrued liabilities

 

 

2,454

 

 

 

3,041

 

Deferred product revenue

 

 

71

 

 

 

63

 

Short-term debt

1,556


3,732

Total current liabilities

 

 

5,901

 

 

 

8,120

 

Operating lease liability, net of current

 

 

949

 

 

 

492

 

Other long-term liabilities

 

 

1,008

 

 

 

1,008

 

Total liabilities

 

 

7,858

 

 

 

9,620

 

 

 

 

 

 

 

 

 

 

Shareholders' equity:

 

 

 

 

 

 

 

 

Common stock, par value $0.001, 50,000,000 shares authorized, 23,955,767 shares issued and outstanding

 

 

24

 

 

 

24

 

Additional paid-in capital

 

 

74,933

 

 

 

74,910

 

Accumulated other comprehensive loss

 

 

(283

)

 

 

(288

)

Accumulated deficit

 

 

(1,348

)

 

 

(516

)

Total shareholders' equity

 

 

73,326

 

 

 

74,130

 

Total liabilities and shareholders' equity

 

$

81,184

 

 

$

83,750

 

 

See accompanying notes

 

 

CLEARONE, INC.

COMPREHENSIVE LOSS

(Dollars in thousands, except per share amounts)

 

 

 

Three months ended March 31,

 

 

 

2023

 

 

2022

 

Revenue

 

$

4,178

 

 

$

7,545

 

Cost of goods sold 

 

 

2,863

 

 

 

4,729

 

Gross profit

 

 

1,315

 

 

 

2,816

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

Sales and marketing

 

 

1,192

 

 

 

1,560

 

Research and product development

 

 

1,043

 

 

 

1,353

 

General and administrative

 

 

1,269

 

 

 

1,756

 

Total operating expenses

 

 

3,504

 

 

 

4,669

 

 

 

 

 

 

 

 

 

 

Operating loss

 

 

(2,189

)

 

 

(1,853

)

 

 

 

 

 

 

 

 

 

Interest expense

(292 )

(101 )

Other income, net

 

 

1,666

 

 

3

 

 

 

 

 

 

 

 

 

Loss before income taxes

 

 

(815

)

 

 

(1,951

)

 

 

 

 

 

 

 

 

 

Provision for income taxes

 

 

17

 

 

 

16

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(832

)

 

$

(1,967

)

 

 

 

 

 

 

 

 

 

Basic weighted average shares outstanding

 

 

23,955,767

 

 

 

23,897,305

 

Diluted weighted average shares outstanding

 

 

23,955,767

 

 

 

23,897,305

 

 

 

 

 

 

 

 

 

 

Basic loss per share

 

$

(0.03

)

 

$

(0.08

)

Diluted loss per share

 

$

(0.03

)

 

$

(0.08

)

 

 

 

 

 

 

 

 

 

Comprehensive loss:

 

 

 

 

 

 

 

 

Net loss

 

$

(832

)

 

$

(1,967

)

Unrealized loss on available-for-sale securities, net of tax

 

 

 

 

(28

)

Change in foreign currency translation adjustment

 

 

5

 

 

(11

)

Comprehensive loss

 

$

(827

)

 

$

(2,006

)

 

See accompanying notes

 

 

CLEARONE, INC.

(Dollars in thousands, except per share amounts)

 

 

 

Three months ended March 31,

 

 

 

2023

 

 

2022

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

Net loss

 

$

(832

)

 

$

(1,967

)

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization expense

 

 

221

 

 

 

794

 

Amortization of right-of-use assets

 

 

129

 

 

 

154

 

Share-based compensation expense

 

 

23

 

 

 

36

 

Change of inventory to net realizable value

 

 

23

 

 

 

 

Gain from disposal of assets



(8 )


Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Receivables

 

 

62

 

 

(86

)

Legal settlement receivable



55,000



Inventories

 

 

365

 

 

 

525

 

Prepaid expenses and other assets

 

 

4,176

 

 

651

Accounts payable

 

 

536

 

 

(1,263

)

Accrued liabilities

 

 

(551

)

 

 

286

Income taxes receivable

 

 

1,293

 

 

(5

)

Deferred product revenue

 

 

8

 

 

(8

)

Operating lease liabilities

 

 

(124

)

 

 

(160

)

Net cash provided by (used in) operating activities

 

 

60,321

 

 

(1,043

)

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Purchase of property and equipment

 

 

(27

)

 

 

(8

)

Purchase of intangibles

 

 

(42

)

 

 

(70

)

Capitalized patent defense costs

 

 

 

 

(189

)

Proceeds from maturities and sales of marketable securities

 

 

 

 

 

2,042

 

Net cash provided by (used in) investing activities

 

 

(69)

 

 

1,775

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Net proceeds from equity-based compensation programs 

 

 

 

 

 

2

 

Principal payments of debt

(2,225 )

(370 )

Net cash used in financing activities

 

 

(2,225

)

 

 

(368

)

 

 

 

 

 

 

 

 

 

Effect of exchange rate changes on cash and cash equivalents

 

 

4

 

 

(13

)

 

 

 

 

 

 

 

 

 

Net increase in cash and cash equivalents 

 

 

58,031

 

 

351

Cash and cash equivalents at the beginning of the period

 

 

986

 

 

 

1,071

 

Cash and cash equivalents at the end of the period 

 

$

59,017

 

 

$

1,422

 

  

See accompanying notes

 


 CLEARONE, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Dollars in thousands, except per share amounts)

 

The following is a summary of supplemental cash flow activities:

 

 

 

Three months ended March 31,

 

 

 

2023

 

 

2022

 

Cash paid for income taxes

 

$

18

 

 

$

26

 

Cash paid for interest 231 51

 

See accompanying notes

 


CLEARONE, INC.

(Unaudited - Dollars in thousands, except per share amounts)

  

1. Business Description, Basis of Presentation and Significant Accounting Policies

 

Business Description:

 

ClearOne, Inc., together with its subsidiaries (collectively, “ClearOne” or the “Company”), is a global market leader enabling conferencing, collaboration, and AV streaming solutions for voice and visual communications. The performance and simplicity of our advanced, comprehensive solutions offer unprecedented levels of functionality, reliability and scalability.

 

Basis of Presentation:

 

The fiscal year for ClearOne is the twelve months ending on December 31. The condensed consolidated financial statements include the accounts of ClearOne and its subsidiaries. All significant inter-company accounts and transactions have been eliminated.

 

These accompanying interim unaudited condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and are not audited. Certain information and footnote disclosures that are usually included in financial statements prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) have been either condensed or omitted in accordance with SEC rules and regulations. The accompanying condensed consolidated financial statements contain all adjustments, consisting of normal recurring accruals, necessary for a fair presentation of our financial position as of March 31, 2023 and December 31, 2022, the results of operations for the three months ended March 31, 2023 and 2022, and the cash flows for the three months ended March 31, 2023 and 2022. The results of operations for the three months ended March 31, 2023 and 2022 are not necessarily indicative of the results for a full-year period. These interim unaudited condensed consolidated financial statements should be read in conjunction with the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC.

 

Significant Accounting Policies:

 

The significant accounting policies were described in Note 1 to the audited consolidated financial statements included in the Company’s annual report on Form 10-K for the year ended December 31, 2022. There have been no changes to these policies during the quarter ended March 31, 2023 that are of significance or potential significance to the Company.


Recent accounting pronouncements: 


In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2016-13, Financial Instruments - Credit Losses (Topic 326). The new standard amends guidance on reporting credit losses for assets held at amortized cost basis and available-for-sale debt securities. In February 2020, the FASB issued ASU 2020-02, Financial Instruments-Credit Losses (Topic 326) and Leases (Topic 842) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases (Topic 842), which amends the effective date of the original pronouncement for smaller reporting companies. ASU 2016-13 and its amendments will be effective for the Company for interim and annual periods in fiscal years beginning after December 15, 2022. CECL estimates of expected credit losses on trade receivables over their life will be required to be recorded at inception, based on historical information, current conditions, and reasonable and supportable forecasts. The Company adopted the standard in its first quarter of 2023. There was no material impact on the results of operations.


The Company has determined that recently issued accounting standards, other than the above discussed, will not have a material impact on its consolidated financial position, results of operations or cash flows.  

 

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except per share amounts)

  

Liquidity:

 

As of March 31, 2023, our cash and cash equivalents were approximately $59,006 compared to $984 as of December 31, 2022. Our working capital was $68,676 as of March 31, 2023. Net cash provided by operating activities was $60,321 for the three months ended March 31, 2023, an increase of $61,364 compared to $1,043 of cash used in operating activities for the three months ended March 31, 2022. The company announced a special one-time cash dividend of $1.00 per share or eligible warrant (please see Note 10 - Subsequent events) which will be paid on May 31, 2023 and is expected to generate cash outflows of approximately $28,978. The Company also paid approximately $6,600 towards income taxes in April 2023. The Company believes that the Company's core strategies of product innovation and prudent cost management will bring the company back to profitability in the future. The Company believes, although there can be no assurance, that the current cash position and all of these measures and effective management of working capital, will provide the liquidity needed to meet our operating needs through at least May 15, 2024. The Company also believes that its strong portfolio of intellectual property and its solid brand equity in the market will enable it to raise additional capital if and when needed to meet its short and long-term financing needs; however, there can be no assurance that, if needed, the Company will be successful in obtaining the necessary funds through equity or debt financing. If the Company needs additional capital and is unable to secure financing, it may be required to further reduce expenses, or delay product development and enhancement.

 

2. Revenue Information

 

The following table disaggregates the Company’s revenue into primary product groups:

 

 

 

Three months ended March 31,

 

 

 

2023

 

 

2022

 

Audio conferencing

 

$

2,329

 

 

$

3,176

 

Microphones

 

 

1,195

 

 

 

2,928

 

Video products

 

 

654

 

 

 

1,441

 

 

 

$

4,178

 

 

$

7,545

 

 

The following table disaggregates the Company’s revenue into major regions: 


 

 

Three months ended March 31,

 

 

 

2023

 

 

2022

 

North and South America 

 

$

1,570

 

 

$

3,776

 

Asia Pacific (includes Middle East, India and Australia)

 

 

1,696

 

 

 

2,074

 

Europe and Africa

 

 

912

 

 

 

1,695

 

 

 

$

4,178

 

 

$

7,545

 


UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited - Dollars in thousands, except per share amounts)


3. Loss Per Share

 

Loss per common share is computed based on the weighted-average number of common shares outstanding and, when appropriate, dilutive potential common stock outstanding during the period. Stock options, warrants and the convertible portion of senior convertible notes are considered to be potential common stock. The computation of diluted earnings (loss) per share does not assume exercise or conversion of securities that would have an anti-dilutive effect. 

 

Basic earnings (loss) per common share is the amount of net earnings (loss) for the period available to each weighted-average share of common stock outstanding during the reporting period. Diluted earnings (loss) per common share is the amount of earnings (loss) for the period available to each weighted-average share of common stock outstanding during the reporting period and to each share of potential common stock outstanding during the period, unless inclusion of potential common stock would have an anti-dilutive effect. 


The following table sets forth the computation of basic and diluted earnings (loss) per common share:

 

 


Three months ended March 31,

 


2023

2022

Numerator:









Net loss


$ (832 )
$ (1,967 )

Denominator:









Basic weighted average shares outstanding



23,955,767


23,897,305

Dilutive common stock equivalents using treasury stock method







Diluted weighted average shares outstanding



23,955,767


23,897,305

 









Basic loss per common share


$ (0.03 )
$ (0.08 )

Diluted loss per common share


$ (0.03 )
$ (0.08 )

 









Weighted average options, warrants and convertible portion of senior convertible notes outstanding



6,368,420


7,062,673

Anti-dilutive options, warrants and convertible portion of senior convertible notes not included in the computation



6,368,420


7,062,673

 


UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except per share amounts)

 

4. Intangible Assets

 

Intangible assets as of March 31, 2023 and December 31, 2022 consisted of the following:

 

 

 

Estimated useful lives (years)

 

 

March 31, 2023

 

 

December 31, 2022

 

Tradename

 

 5

to

7

 

 

$

555

 

 

$

555

 

Patents and technological know-how

 

10

to

20

 

 

 

7,094

 

 

 

7,053

 

Proprietary software

 

 3

to

15

 

 

 

2,981

 

 

 

2,981

 

Other

 

 3

to

5

 

 

 

323

 

 

 

323

 

Total intangible assets

 

 

 

 

 

 

 

10,953

 

 

 

10,912

 

Accumulated amortization

 

 

 

 

 

 

 

(8,958

)

 

 

(8,841

)

Total intangible assets, net

 

 

 

 

 

 

$

1,995

 

 

$

2,071

 

 

The amortization of intangible assets for the three months ended March 31, 2023 and 2022 was as follows: 

 

 


Three months ended March 31,

 


2023

2022

Amortization of intangible assets


$ 118

$ 670

 

The estimated future amortization expense of intangible assets is as follows:

 

Years ending December 31,

 

Amount

 

2023 (Remainder)

 

$

398

 

2024

 

 

253

 

2025

 

 

192

 

2026

 

 

191

 

2027

 

 

61

 

Thereafter

 

 

900

 

Total

 

$  

1,995

 

 

 

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except per share amounts) 


5. Inventories

 

Inventories, net of reserves, as of March 31, 2023 and December 31, 2022 consisted of the following:  

 

 

 

March 31, 2023

 

 

December 31, 2022

 

Current:

 

 

 

 

 

 

 

 

Raw materials

 

$

4,552

 

 

$

4,499

 

Finished goods

 

 

3,843

 

 

 

4,462

 

 

 

$

8,395

 

 

$

8,961

 

 

 

 

 

 

 

 

 

 

Long-term:

 

 

 

 

 

 

 

 

Raw materials

 

$

928

 

 

$

1,068

 

Finished goods

 

 

1,957

 

 

 

1,639

 

 

 

$

2,885

 

 

$

2,707

 

  

Long-term inventory represents inventory held in excess of our current (next 12 months) requirements based on our recent sales and forecasted level of sales. We expect to sell the above inventory, net of reserves, at or above the stated cost and believe that no loss will be incurred on its sale, although there can be no assurance of the timing or amount of any sales. 

 

Net loss incurred on valuation of inventory at lower of cost or market value and write-off of obsolete inventory for three months ended March 31, 2023 and 2022 was as follows:   

 

 


Three months ended March 31,

 


2023

2022

Net loss incurred on valuation of inventory at lower of cost or market value and write-off of obsolete inventory


$ 23

$

 

6. Leases

 

Rent expense is recognized on a straight-line basis over the period of the lease taking into account future rent escalation and holiday periods. 

 

Rent expense for three months ended March 31, 2023 and 2022 was as follows: 

 

 

 

Three months ended March 31,

 

 

 

2023

 

 

2022

 

Rent expense

 

$

149

 

 

$

179

 

The Company occupies a 1,350 square-foot facility in Gainesville, Florida under the terms of an operating lease expiring in February 2028The Gainesville facility is used primarily to support the Company's research and development activities. 

 

The Company occupies a 9,402 square-foot facility in Salt Lake City, Utah under the terms of an operating lease expiring in February 2028. The facility supports the Company's principal administrative, sales, marketing, customer support, and research and product development activities. 


UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except per share amounts)


The Company occupies a 6,175 square-foot facility in Chennai, India under the terms of an operating lease expiring in August 2023. This facility supports the Company's administrative, marketing, customer support, and research and product development activities.

 

The Company occupies a 40,000 square-foot warehouse in Salt Lake City, Utah under the terms of an operating lease expiring in April 2025, which serves as the Company's primary inventory fulfillment center.  


Supplemental cash flow information related to leases was as follows: 

 

 

 

Three months ended March 31,

 

 

 

2023

 

 

2022

 

Cash paid for amounts included in the measurement of lease liabilities

 



 

 



 

Operating cash flows from operating leases
$ (151 )
$ (183 )
Right-of-use assets obtained in exchange for lease obligations:







Operating leases
$ 758

$

 

Supplemental balance sheet information related to leases was as follows:

 

 

 

March 31, 2023

 

 

December 31, 2022

 

Operating lease right-of-use assets

 

$

 1,259

 

 

 $

 1,047

 


 








Current portion of operating lease liabilities, included in accrued liabilities
$ 382

$ 641

Operating lease liabilities, net of current portion

 

 

949

 

 

 

492

 

Total operating lease liabilities

 

$

1,331

 

 

$

1,133

 

 

 

 

 

 

 

 

 

 

Weighted average remaining lease term for operating leases (in years) 

4


2.12
Weighted average discount rate for operating leases

6.37 %

5.93 %

  

The following represents maturities of operating lease liabilities as of March 31, 2023:

 

Years ending December 31,

 

 

 

 

2023 (Remainder)

 

$

341

 

2024

 

 

439

 

2025

 

 

272

 

2026

 

 

210

 

2027

 

 

216

 

Thereafter

37

Total lease payments

 

 

1,515

 

Less: Imputed interest

 

 

(184

)

Total

 

$

1,331

 


 

UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited - Dollars in thousands, except per share amounts)

 

7. Shareholders' Equity

 

 

 

Three months ended March 31,

 

 

 

2023

 

 

2022

 

Common stock and additional paid-in capital

 

 

 

 

 

 

 

 

Balance, beginning of period

 

$

74,934

 

 

$

72,818

 

Issuance of common stock and warrants, net

 


2,000

Share-based compensation expense

 

 

22

 

 

 

35

 

Proceeds from employee stock purchase plan

 

 

1

 

 

 

2

 

Balance, end of period

 

$

74,957

 

 

$

74,855

 

 

 

 

 

 

 

 

 

 

Accumulated other comprehensive loss

 

 

 

 

 

 

 

 

Balance, beginning of period

 

$

(288

)

 

$

(241

)

Unrealized loss on available-for-sale securities, net of tax 

 

 

 

 

(28

)

Foreign currency translation adjustment

 

 

5

 

 

(11

)

Balance, end of period

 

$

(283

)

 

$

(280

)

 

 

 

 

 

 

 

 

 

Accumulated deficit 

 

 

 

 

 

 

 

 

Balance, beginning of period

 

$

(516

)

 

$

(21,072

)

Net loss

 

 

(832

)

 

 

(1,967

)

Balance, end of period

 

$

(1,348

)

 

$

(23,039

)

 

 

 

 

 

 

 

 

 

Total shareholders' equity

 

$

73,326

 

 

$

51,536

 

 

Issue of Common Stock and Warrants


On  September 12, 2021, the Company entered into a securities purchase agreement with certain purchasers named therein, pursuant to which the Company issued 3,623,189 shares of the Company's common stock, par value $0.001 per share at an offering price of $2.76 per share. The Company received gross proceeds of approximately $10,000 and net proceeds of $9,288 after deducting placement agent fees and related offering expenses. In a concurring private placement the Company also issued to the same purchasers warrants exercisable for an aggregate of 3,623,189 shares of common stock at an exercise price of $2.76 per share. Each warrant became immediately exercisable and will expire on March 15, 2027.


On January 4, 2022, the Company entered into a Securities Purchase Agreement with Edward D. Bagley, an affiliate of the Company, pursuant to which the Company agreed to issue and sell, in a private placement 1,538,461 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share, at a purchase price of $1.30 per share of Common Stock. The consideration for the Shares is the cancellation and termination of Mr. Bagley’s outstanding bridge loan to the Company in the principal amount of $2,000 originally issued on July 2, 2021 and amended and restated on September 11, 2021. Mr. Bagley is an affiliate of the Company and the Company’s single largest stockholder.  



UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except per share amounts)


8. Debt

Senior Convertible Notes and Warrants 


On December 17, 2019, the Company completed the issuance and sale of $3,000 aggregate principal amount of secured convertible notes of the Company (the “Notes”) and warrants (the “Warrants”) to purchase 340,909 shares of common stock, par value $0.001 per share of the Company (the “Common Stock”), in a private placement transaction. The Notes and Warrants were issued and sold to Edward D. Bagley, an affiliate of the Company, on the terms and conditions of a Note Purchase Agreement dated December 8, 2019 between the Company, certain subsidiary guarantors of the Company, and Mr. Bagley. Mr. Bagley was the beneficial owner of approximately 46.6% of the Company’s issued and outstanding shares of Common Stock at the time that the Notes and Warrants were issued to him.

The Notes will mature on December 17, 2023 (the “Maturity Date”) and will accrue interest at a variable rate adjusted on a quarterly basis and equal to two and one-half percent (2.5%) over the greater of (x) five and one-quarter percent (5.25%) and (y) the Prime Rate as published in the Wall Street Journal (New York edition) as of the beginning of such calendar quarter.  The Notes may be converted into shares of the Company’s Common Stock at any time at the election of Mr. Bagley at an initial conversion price of $2.11 per share (the “Conversion Price”), or 120% of the closing price of the Common Stock on December 6, 2019 as reported on the Nasdaq Capital Market. Also, the Company can cause a mandatory conversion of the Notes if the volume weighted average closing price of the Common Stock over 90 consecutive trading days exceeds 200% of the Conversion Price. In addition, the Notes may be redeemed by the Company for cash at any time after December 17, 2020 upon payment of the outstanding principal balance of the Notes and any unpaid and accrued interest.  The Company also is required to redeem the Notes upon the occurrence of a change in control of the Company.

The Warrants have an initial exercise price equal to $1.76, the closing price of the Common Stock on December 6, 2019 as reported on the Nasdaq Capital Market, and are exercisable until December 17, 2026.  The Warrants must be exercised for cash, unless at the time of exercise there is not a then effective registration statement for the resale of the shares of Common Stock issuable upon exercise of the Warrants, in which case the Warrants may be exercised via a cashless exercise feature that provides for net settlement of the shares of Common Stock issuable upon exercise. 

Concurrent with the issuance of the Notes and Warrants pursuant to the Note Purchase Agreement, the Company, the Guarantors and Mr. Bagley entered into a Guaranty and Collateral Agreement (the “Collateral Agreement”) pursuant to which the Company and the Guarantors granted Mr. Bagley a first priority lien interest in all of the Company’s assets as security for the Company’s performance of its obligations under the Notes and Warrants.

The net proceeds after original issue discount and issuance costs of $346 were approximately $2,654. The Company expected to use the proceeds from the sale of the Notes and Warrants for general corporate purposes and working capital. 

In accounting for the issuance of the Notes, the Company separated Notes and Warrants into liability and equity components. The carrying amount of Warrants, being an equity component, was first calculated using Black-Scholes method with the following assumptions:


Risk-free interest rate

1.82%

Expected life of warrants (years)

7

Expected price volatility

49.4%

Expected dividend yield

0%

The carrying amount of the Notes was then determined by deducting the fair value of the Warrants from the principal amount of the Notes. The carrying amount of the Notes was further separated into equity and liability components after separating the value of the conversion feature into an equity component and leaving the remaining value as liability. The equity component is not remeasured while the Notes and Warrants continue to meet the conditions for equity classification for equity components.

The original issue discount and issuance costs are netted against the liability. The following table represents the carrying value of Notes and Warrants: 



UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollars in thousands, except per share amounts)

 

 

 

March 31, 2023

 

 

December 31, 2022

 

Liability component:

 

 

 

 

 

 

 

 

Principal

 

$

1,695

 

 

$

1,920

 

Less: debt discount and issuance costs, net of amortization

 

 

(139

)

 

 

(188

Net carrying amount

 

$

1,556

 

 

$

1,732

 

Equity component(1):

 

 

 

 

 

 

 

 

Warrants

 

$

318

 

 

$

318

 

Conversion feature

 

122

 

 

122

 

Net carrying amount

 

$

440

 

 

$

440

 










Current portion of liability component included under short-term debt
$ 1,556

$ 1,920
Liability component total
$ 1,556

$ 1,920

(1) Recorded on the condensed consolidated balance sheets as additional paid-in capital. 


Debt discount and issuance costs are amortized over the life of the note to interest expense using the effective interest method. During the three months ended March 31, 2023 and March 31, 2022 amortization of debt discount and issuance costs was $49 and $49, respectively. The following table represents schedule of maturities of principal amount contained in the Notes as of March 31, 2023:


Year ending December 31,

 

Principal Amount Maturing

 

2023 (Remainder)

 

 

1,695

 

Total principal amount

 

$

1,695

 


Short-term Bridge Loans


On July 2, 2021, the Company obtained a bridge loan in the principal amount of $2,000 from Edward D. Bagley (the “2021 Bridge Loan”), an affiliate of the Company. The Bridge Loan was evidenced by a promissory note dated July 2, 2021 (the “Note”) issued by the Company to Mr. Bagley.  The Note bore interest at a rate of 8.0% per annum. On September 11, 2021, the Company amended and restated the terms of the Bridge Loan to extend the latest maturity date from October 1, 2021 to January 3, 2022. All other terms and conditions of the Bridge Loan remained the same. On January 4, 2022, the Company entered into a Securities Purchase Agreement with Edward D. Bagley, pursuant to which the Company issued and sold to Mr. Bagley, in a private placement 1,538,461 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share, at a purchase price of $1.30 per share of Common Stock. The consideration for the Shares was the cancellation and termination of Mr. Bagley’s outstanding bridge loan to the Company in the principal amount of $2,000 originally issued on July 2, 2021 and amended and restated on September 11, 2021. Mr. Bagley is an affiliate of the Company and the Company’s single largest stockholder.


On October 28, 2022 the Company obtained a bridge loan in the principal amount of $2,000 from Edward D. Bagley (the “2022 Bridge Loan”), an affiliate of the Company. The 2022 Bridge Loan was evidenced by a promissory note dated October 28, 2022 (the “2022 Note”) issued by the Company to Mr. Bagley. The 2022 Note bore interest at a rate of 12.0% per annum and had a maturity date of October 28, 2023. Mr. Bagley is an affiliate of the Company and the Company’s single largest stockholder. This Bridge Loan of $2,000 is included under short-term debt as of December 31, 2022. In January 2023, the 2022 Bridge loan of $2,000 along with applicable interest was repaid in full.

 


UNAUDITED NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited - Dollars in thousands, except per share amounts)

 

9. Income Taxes

 

The current year loss did not result in income tax benefit due to recording a full valuation allowance against expected benefits. The valuation allowance was recorded as we concluded that it was more likely than not that our deferred tax assets were not realizable primarily due to the Company's recent pre-tax losses. Provision for income taxes for the three months ended March 31, 2023 mostly represents income tax expense recorded for jurisdictions outside the United States.  


The Company had approximately $962 of uncertain tax positions as of March 31, 2023. Due to the inherent uncertainty of the underlying tax positions, it is not possible to forecast the payment of this liability for any particular year.


10. Subsequent events

 

On May 8, 2023, the Company announced that the Company’s Board of Directors had declared a special one-time cash dividend of $1.00 per share of the Company’s common stock or eligible warrants, payable on May 31, 2023 to shareholders of record on May 22, 2023. This is expected to result in cash outflow of approximately, $28,978.



 

This report on Form 10-Q includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements in this report, other than statements of historical fact, are forward-looking statements for purposes of these provisions, including any projections of earnings, revenues or other financial items, any statements of the plans and objectives of management for future operations, any statements concerning proposed new products or services, any statements regarding future economic conditions or performance, and any statements of assumptions underlying any of the foregoing. All forward-looking statements included in this report are made as of the date hereof and are based on information available to us as of such date. We assume no obligation to update any forward-looking statement. In some cases, forward-looking statements can be identified by the use of terminology such as “may,” “will,” “expects,” “plans,” “anticipates,” “intends,” “believes,” “estimates,” “potential,” or “continue,” or the negative thereof or other comparable terminology. Although we believe that the expectations reflected in the forward-looking statements contained herein are based upon reasonable assumptions at the time made, there can be no assurance that any such expectations or any forward-looking statement will prove to be correct. Our actual results will vary, and may vary materially, from those projected or assumed in the forward-looking statements. Future financial condition and results of operations, as well as any forward-looking statements, are subject to inherent risks and uncertainties, many of which we cannot predict with accuracy and some of which we might not anticipate, including, without limitation, product recalls and product liability claims; infringement of our technology or assertion that our technology infringes the rights of other parties; termination of supplier relationships, or failure of suppliers to perform; inability to successfully manage growth; delays in obtaining regulatory approvals or the failure to maintain such approvals; concentration of our revenue among a few customers, products or procedures; development of new products and technology that could render our products obsolete; market acceptance of new products; introduction of products in a timely fashion; price and product competition, availability of labor and materials, cost increases, and fluctuations in and obsolescence of inventory; volatility of the market price of our common stock; foreign currency fluctuations; changes in key personnel; work stoppage or transportation risks; integration of business acquisitions; and other factors referred to in our reports filed with the SEC, including our Annual Report on Form 10-K for the year ended December 31, 2022. All subsequent forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. Additional factors that may have a direct bearing on our operating results are discussed in Part II, Item 1A “Risk Factors” in this Quarterly Report on Form 10-Q and in  Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022.

 

BUSINESS OVERVIEW

 

ClearOne is a global Company that designs, develops and sells conferencing, collaboration, and AV networking solutions for voice and visual communications. The performance and simplicity of our advanced, comprehensive solutions offer a high level of functionality, reliability and scalability. We derive a major portion of our revenue from audio conferencing products and microphones by promoting our products in the professional audio-visual channel. We have extended our total addressable market from the installed audio conferencing market to adjacent complementary markets – microphones, video collaboration and AV networking. We have achieved this through strategic technological acquisitions as well as by internal product development. 

 

On January 30, 2023, we introduced the new CHAT® 150 BT group speakerphone with USB and Bluetooth connectivity that enhances the conferencing experience for the ultimate in business class performance. With simple, instant connection to personal computers, mobile devices or Bluetooth-enabled desk phones, the CHAT® 150 BT group speakerphone provides users with an affordable way to upgrade home offices, executive offices, and mid-size meeting rooms with BYOD convenience and superior audio clarity for audio conferences and video meetings. The CHAT® 150 BT speakerphone also has an audio bridging feature that allows far end conference participants connected via a software conferencing application through USB, local users of the speakerphone, and far end callers on a mobile call connected through Bluetooth to all join the same call and hear each other clearly. Featuring a steerable microphone array with first-mic priority, the CHAT® 150 BT speakerphone intelligently activates the microphone closest to the person speaking, reducing interference from ambient noise. Like all ClearOne microphone products, the CHAT® 150 BT speakerphone is compatible with popular collaboration platforms including Microsoft® Teams, Zoom™, WebEx™, Google® Meet™, and many more. The new BT model retains all the class-leading features of the original CHAT® 150 speakerphone, including Advanced Noise Cancellation, Full Duplex Distributed Echo Cancellation™ and Automatic Level Control algorithms, to ensure highly intelligible, natural audio capture and playback. It also supports NFC tap-to-pair and includes a wired USB connection for compatibility with the full variety of modern devices.  



MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS


On January 16, 2023, we introduced UNITE 260 Pro camera, a professional grade 4K Ultra HD camera featuring both a 20X optical zoom and 16X digital zoom that allows users to capture every participant in all meeting, training, and learning environments it is deployed in. Compatible with all popular meeting applications like Microsoft® Teams, Zoom™, WebEx™, and Google® Meet™, the new camera features an AI-based smart face tracking mode that keeps a selected presenter in the frame as they move about the room. Alternatively, the camera’s AI-based auto framing mode always keeps an entire group in perfect view. With dual video outputs HDMI and IP, the UNITE 260 Pro Camera is an excellent choice for a hybrid environment: streaming content while simultaneously showing it live where the presentation is occurring.


We continued our programs to cut costs and to speed up product development that we believe will enable us to get back to a growth path.

 

Overall revenue decreased by 45% in the first quarter of 2023 when compared to the first quarter of 2022, primarily due to a significant decrease in revenues from all product categories, especially microphones. The revenue decline was primarily due to our continued inability to source adequate inventory to meet the demand for professional audio products and BMA due to the ongoing transition of manufacturing of our products from China to Singapore by our electronics manufacturing services provider and due to the decline in demand for video products. We expect the challenges with the manufacturing transition from China to Singapore to ease in the second half of 2023.  Our revenue performance in 2023-Q1 was also partially impacted negatively due to increased costs associated with the electronic raw material supply shortages that have affected the global manufacturing of high tech products. We expect these supply shortages and associated increased costs to continue through at least the end of 2023.


Our gross profit margin decreased to 31.5% during the first quarter of 2023 from 37.3% during the first quarter of 2022. Gross Profit margin decreased year over year mainly due to increase in administration and overhead costs as a percentage of revenue and increase in inventory obsolescence costs.


Net loss decreased from $2.0 million in the first quarter of 2022 to $0.8 million in the first quarter of 2023. The decrease in net loss was mainly due to a receipt of $1.35 million from a one-time legal settlement of a contract dispute. This receipt, included in other income was partially offset by an increase in operating losses of $0.3 million. 

 


MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Industry conditions

 

We operate in a very dynamic and highly competitive industry which is dominated on the one hand by a few players with respect to certain products like traditional video conferencing appliances while on the other hand influenced heavily by a fragmented reseller market consisting of numerous regional and local players. The industry is also characterized by venture capitalist funded start-ups and private companies willing to fund cumulative cash losses in order to gain market share and achieve certain non-financial goals. It has become increasingly important to have higher interoperability with other products in the audio visual market as well as with leading video conferencing service providers like Microsoft and Zoom

 

Economic conditions, challenges and risks

 

The audio-visual products market is characterized by intense competition and rapidly evolving technology. Our competitors vary within each product category. Our installed professional audio conferencing products, which is our flagship product category, continue to be ahead of the competition despite the reduction in revenues. Our strength in this space is largely due to our fully integrated suite of products consisting of DSP mixers, wide range of professional microphone products and video collaboration products. Despite our strong leadership position in the installed professional audio conferencing market, we face challenges to revenue growth due to the limited size of the market, pricing pressures from new competitors attracted to the commercial market due to higher margins, our limited ability to be interoperable with other audio visual products in the market, and the lack of certifications from Microsoft.


Our video products and beamforming microphone arrays, especially highly advanced BMA 360 and BMA-CT are critical to our long-term growth. We face intense competition in this market from well-established market leaders as well as emerging players rich with marketing funds. We expect our strategy of making our products more interoperable with other audio-visual products, continuing to improve the quality of our high-end audio conferencing products and microphones, and offering a wide range of innovative professional cameras will generate high growth in the near future. 

 

We derive a significant portion of our revenue (approximately 52% in 2022) from international operations and expect this trend to continue in the future. Most of our revenue from outside the U.S. is billed in U.S. dollars and is not exposed to any significant currency risk. However, we are exposed to foreign exchange risk if the U.S. dollar is strong against other currencies as it will make U.S. Dollar denominated prices of our products less competitive.

 

In December 2019, a novel strain of coronavirus (“COVID-19”) started spreading from China and was declared a pandemic. The COVID-19 pandemic caused severe global disruptions and had varying impact on our business.  The installed audio conferencing market was negatively impacted due to lockdowns, postponement of projects and restrictions on installers to visit commercial sites. On the other hand, COVID-19 generated higher than normal demand in 2020 for our video products and personal conferencing products due to the significant expansion of work-from-home market. The extent of COVID-19’s effect on our operational and financial performance keeps evolving and depends on multiple factors including the severity and infectiousness of current and future virus strains, effectiveness of vaccines especially on novel strains of COVID-19, government regulations, etc., all of which are uncertain and difficult to predict considering the rapidly evolving landscape. Supply chain disruptions resulting from COVID-19 have caused significant fluctuations in our costs of goods resulting in a reduction of our gross margins in 2021 and 2022. We expect these fluctuations to continue in 2023. If the pandemic continues to be a severe worldwide health crisis, the disease could have a material adverse effect on our business, results of operations, financial condition and cash flows and adversely impact the trading price of our common stock.

 

Deferred Product Revenue

 

Deferred product revenue increased to $71 thousand on March 31, 2023 compared to $63 thousand on December 31, 2022.

 

A detailed discussion of our results of operations follows below.

 

 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Results of Operations for the three months ended March 31, 2023

 

The following table sets forth certain items from our unaudited condensed consolidated statements of operations for the three months ended March 31, 2023 (“2023-Q1”) ("2023-YTD") and 2022 ("2022-Q1") ("2022-YTD"), respectively, together with the percentage of total revenue which each such item represents:    


   

Three months ended March 31,


(dollars in thousands)  

2023

   

2022

    Change Favorable (Adverse) in %

Revenue

  $ 4,178     $ 7,545       (45 )

Cost of goods sold

    2,863       4,729       39

Gross profit

    1,315     2,816       (53 )

Sales and marketing

    1,192       1,560       24

Research and product development

    1,043       1,353       23

General and administrative

    1,269       1,756       28

Total operating expenses 

    3,504       4,669    
25

Operating loss

    (2,189 )     (1,853 )     (18 )

Other income (expense), net

    1,374     (98 )     1,502

Loss before income taxes

    (815 )     (1,951 )     58

Provision for income taxes

    17       16     (6 )

Net loss

  $ (832 )   $ (1,967 )     58

 

Revenue

 

Our revenue decreased to $4.2 million in 2023-Q1 compared to $7.5 million in 2022-Q1 due to a 59% decline in microphones, a 55% decline in video products, and a 27% decline in audio conferencing. Except for wireless mics and premium audio conferencing, both of which constitute a small percentage of our revenue all other product categories suffered revenue declines year over year. Revenues from BMA and professional audio conferencing products were negatively impacted by our inability to source adequate inventory to meet the demand for professional audio products and BMA due to the ongoing transition of manufacturing of our products from China to Singapore by our electronics manufacturing services provider.  Our traditional ceiling mics, personal audio conferencing products, video cameras and video conferencing equipment suffered revenue declines due to lack of demand. During the first quarter of 2023, revenues from Americas declined by 58% primarily due to decreased revenues from all the regions. During 2023-Q1 revenues from the Asia Pacific, including the Middle East, India and Australia decline by 18% primarily due to declines in revenues from all sub-markets except India and Australia. Finally, revenues from Europe and Africa decreased significantly by 46% in 2023-Q1 primarily due to decreases across all the sub-markets except Central Europe. 


We believe, although there can be no assurance, that we can return to generating operating profits through our strategic initiatives namely product innovation and cost reduction. 

 

Costs of Goods Sold and Gross Profit  

 

Cost of goods sold includes expenses associated with finished goods purchased from outsourced manufacturers, the repackaging of our products, our manufacturing and operations organization, property and equipment depreciation, warranty expense, freight expense, royalty payments, and the allocation of overhead expenses.


Our gross profit margin decreased from 37.3% during 2022-Q1 to 31.5% during 2023-Q1. The gross profit margin was negatively impacted due to increases in material costs due to mainly due to increase in administration and overhead costs as a percentage of revenue and increase in inventory obsolescence costs


 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Our profitability in the near-term continues to depend significantly on our revenues from professional installed audio-conferencing products. We hold long-term inventory and if we are unable to sell our long-term inventory, our profitability might be affected by inventory write-offs and price mark-downs. Our long-term inventory includes approximately $0.5 million of wireless microphone-related finished goods and assemblies, $0.3 million of Converge Pro and Beamforming microphone array products, $1.0 million of video products, and $0.9 million of raw materials that will be used primarily for manufacturing professional audio conferencing products and BMA microphones. Any business changes that are adverse to these product lines could potentially impact our ability to sell our long-term inventory in addition to our current inventory.

 

Operating Expenses

 

Operating expenses include sales and marketing (“S&M”) expenses, research and product development (“R&D”) expenses and general and administrative (“G&A”) expenses. Total operating expenses in 2023-Q1  was $3.5 million compared to $4.7 million in 2022-Q1. The following contains a more detailed discussion of expenses related to sales and marketing, research and product development, general and administrative, and other items. 

Sales and Marketing - S&M expenses include selling, customer service, and marketing expenses such as employee-related costs, allocations of overhead expenses, trade shows, and other advertising and selling expenses.

 

S&M expenses in 2023-Q1 decreased to $1.2 million from $1.6 million for 2022-Q1. The decrease was primarily due to decreases in employment expenses and consultant expenses due to a reduction in the headcount and due to decrease in commissions paid to employees and consultants.  


Research and Product Development - R&D expenses include research and development, product line management, engineering services, and test and application expenses, including employee-related costs, outside services, expensed materials, depreciation, and an allocation of overhead expenses.

 

R&D expenses decreased to $1.0 million in 2023-Q1 compared to $1.4 million for 2022-Q1. The decrease was primarily due to reduction in employment expenses due to reduction in the headcount and a decrease in project-related expenses.

  

General and Administrative - G&A expenses include employee-related costs, professional service fees, allocations of overhead expenses, litigation costs, and corporate administrative costs, including costs related to finance and human resources teams.

 

G&A expenses decreased to $1.3 million in 2023-Q1 compared to $1.8 million in 2022-Q1. The reduction was primarily due to (i) a decrease in amortization costs relating to our capitalized patent defense costs, which was fully amortized in 2022-Q4, (ii) a decline in audit fees, (iii) and a decline in employment-related expenses, partially offset by (iv) increase in legal expenses, and (v) insurance expenses.

 

Other income (expense), net

 

Other income (expense), net includes interest income, foreign currency changes and gain or loss on disposal of assets. Other income in 2023-Q1 included a receipt of $1.35 million from a one-time legal settlement of a contract dispute. Other items included in other income remained immaterial during 2023-Q1 and 2022-Q1.

 

Interest expense increased to $0.3 million in 2023-Q1 compared to $0.1 million in 2022-Q1. primarily due to interest associated with the prepayment of the $2 million bridge loan in January 2023.


Provision for income taxes

 

During each of the three months ended March 31, 2023 and 2022, we did not recognize any benefit from the losses incurred due to setting up a full valuation allowance.

 


MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

LIQUIDITY AND CAPITAL RESOURCES

 

As of March 31, 2023, our cash and cash equivalents were approximately $59.0 million compared to $1.0 million as of December 31, 2022. Our working capital was $68.7 million and $69.3 million as of March 31, 2023 and December 31, 2022, respectively. 

 

Net cash provided by operating activities was approximately $60.3 million in 2023-Q1, an increase of cash provided by operating activities of approximately $61.4 million from $1.0 million of cash used by operating activities in 2022-Q1. The increase in cash inflow was primarily due to $56.4 million in receipts from legal settlements, the receipt of $4.5 million from the return of a bond deposited with a court, and a $1.3 million refund of income taxes with interest. These receipts were partially offset by operating losses.  

 

Net cash used in investing activities in 2023-Q1 was $0.1 million compared to $1.8 million of net cash provided by investing activities in 2022-Q1. In 2022-Q1 cash provided by investing activities primarily consisted of $2.0 million in proceeds from sale of marketable securities, partially offset by capitalized patent defense costs of $0.2 million. 


Net cash used in financing activities in 2023-Q1 was $2.2 million, comprised primarily of repayment of the bridge loan of $2.0 million and $0.2 million payments of principal amounts due on senior convertible debt. This compares to $0.4 million used in principal amounts due on senior convertible debt in 2022-Q1 . 

 

As of March 31, 2023, our cash and cash equivalents were approximately $59.0 million compared to $1.0 million as of December 31, 2022. Our working capital was $68,7 million as of March 31, 2023. Net cash provided by operating activities was $60.3 million for the three months ended March 31, 2023, an increase of $61.4 million compared to $1.0 million of cash used in operating activities for the three months ended March 31, 2022. The company announced a special one-time cash dividend of $1.00 per share or eligible warrant (please see Note 10 - Subsequent events) which will be paid on May 31, 2023 and is expected to generate cash outflows of approximately $29.0 million. The Company also paid approximately $6.6 million towards income taxes in April 2023. The Company believes that the Company's core strategies of product innovation and prudent cost management will bring the company back to profitability in the future. The Company believes, although there can be no assurance, that the current cash position and all of these measures and effective management of working capital, will provide the liquidity needed to meet our operating needs through at least May 15, 2024. The Company also believes that its strong portfolio of intellectual property and its solid brand equity in the market will enable it to raise additional capital if and when needed to meet its short and long-term financing needs; however, there can be no assurance that, if needed, the Company will be successful in obtaining the necessary funds through equity or debt financing. If the Company needs additional capital and is unable to secure financing, it may be required to further reduce expenses, or delay product development and enhancement.


As of March 31, 2023, we had open purchase orders of approximately $1.6 million mostly for the purchase of inventory.  

 

As of March 31, 2023, we had inventory totaling $11.3 million, of which non-current inventory accounted for $2.9 million. This compares to total inventories of $11.7 million and non-current inventory of $2.7 million as of December 31, 2022.

 


MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Contractual Obligations and Commitments

 

The following table summarizes our contractual obligations as of March 31, 2023 (in millions): 

 

 

 

Payment Due by Period

 

 

 

Total

 

 

Less Than

1 Year

 

 

1-3 Years

 

 

3-5 Years

 

 

More than 5

years

 

Senior convertible notes

 

$

1.7

 

 

$

1.7

 

 

$

 

 

$

 

 

$

 

Operating lease obligations

 

 

1.5

 

 

 

0.4

 

 

 

0.7

 

 

 

0.4

 

 

 

 

Purchase obligations

 

 

1.6

 

 

 

1.6

 

 

 

 

 

 

 

 

 

 

Total

 

$

4.8

 

 

$

3.7

 

 

$

0.7

 

 

$

0.4

 

 

$

 

  

OFF-BALANCE SHEET ARRANGEMENTS

 

We have no off-balance-sheet arrangements that have or are reasonably likely to have a current or future material effect on our financial condition, changes in financial conditions, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources, results of operations or liquidity.   


CRITICAL ACCOUNTING POLICIES AND ESTIMATES

 

Our discussion and analysis of our results of operations and financial position are based upon our unaudited condensed consolidated financial statements included under Item 1 of this Form 10-Q, which have been prepared in conformity with accounting principles generally accepted in the United States. We review the accounting policies used in reporting our financial results on a regular basis. We believe certain of our accounting policies are critical to understanding our financial position and results of operations. There have been no changes to the critical accounting policies as explained in our Annual Report on Form 10-K for the year ended December 31, 2022.

 

RECENT ACCOUNTING PRONOUNCEMENTS

 

For a discussion of recent accounting pronouncements, see Note 1: “Business Description, Basis of Presentation and Significant Accounting Policies” in the notes to our unaudited condensed consolidated financial statements included under Item 1 of this Form 10-Q.


 

Not applicable.

 

 

An evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of March 31, 2023 was performed under the supervision and with the participation of our management, including our Chief Executive Officer and our Principal Financial and Accounting Officer. Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this Quarterly Report, our disclosure controls and procedures are effective at a reasonable assurance level as of March 31, 2023.

 

There has been no change in the Company's internal control over financial reporting as of March 31, 2023, that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting. 

 

 

 

 

None. 

 

 

None.


 

(a)  None.


(b) Not applicable.


(c) None. 


 

(a)  Not applicable.


(b) Not applicable.

 

 

Not applicable.

 

 

(a)  Not applicable.


(b) Not applicable.


(c) Not applicable. 




Item 6. EXHIBITS

 

Exhibit No.

 

Title of Document

 

 

 

31.1

 

Section 302 Certification of Chief Executive Officer (filed herewith)

 

 

 

31.2

 

Section 302 Certification of Principal Financial Officer (filed herewith)

 

 

 

32.1

 

Section 906 Certification of Chief Executive Officer (filed herewith)

 

 

 

32.2

 

Section 906 Certification of Principal Financial Officer (filed herewith)

 

 

 

101.INS

 

XBRL Instance Document (filed herewith) 

 

 

 

101.SCH

 

XBRL Taxonomy Extension Schema (filed herewith)

 

 

 

101.CAL

 

XBRL Taxonomy Extension Calculation Linkbase (filed herewith)

 

 

 

101.DEF

 

XBRL Taxonomy Extension Definitions Linkbase (filed herewith)

 

 

 

101.LAB

 

XBRL Taxonomy Extension Label Linkbase (filed herewith)

 

 

 

101.PRE

 

XBRL Taxonomy Extension Presentation Linkbase (filed herewith)




104.1
The cover page of this Quarterly Report on Form 10-Q, formatted in Inline XBRL.

 


SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

ClearOne, Inc.,

(Registrant)

 

 

 

 

By:

/s/ Derek L. Graham

May 15, 2023

 

Derek L. Graham

Chief Executive Officer

(Principal Executive Officer)

 

 

 

 

By:

/s/ Narsi Narayanan

May 15, 2023 

 

Narsi Narayanan

Chief Financial Officer

(Principal Accounting and Principal Financial Officer)

 

 

26

EXHIBIT 31.1

 

CERTIFICATION

 

I, Derek L. Graham, certify that:

 

1.

I have reviewed this quarterly report of ClearOne, Inc. on Form 10-Q;




2.


Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;




3.


Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;




4.


The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

 

 

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

 

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

 

 

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

 

 

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

By:

/s/ Derek L. Graham

May 15, 2023

 

Derek L. Graham

Chief Executive Officer

(Principal Executive Officer)

 


EXHIBIT 31.2

 

CERTIFICATION

 

I, Narsi Narayanan, certify that:

 

1.

I have reviewed this quarterly report of ClearOne, Inc. on Form 10-Q;

 

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

 

 

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

 

 

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

 

 

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

 

 

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

By:

/s/ Narsi Narayanan

May 15, 2023

 

Narsi Narayanan

Chief Financial Officer

(Principal Accounting and Principal Financial Officer)

 

EXHIBIT 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

 

Pursuant to 18 U.S.C. Section 1350,

As adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

I, Derek L. Graham, certify, to my best knowledge and belief, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of ClearOne, Inc. on Form 10-Q for the quarter ended March 31, 2023 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of ClearOne, Inc.

 

 

By:

/s/ Derek L. Graham

May 15, 2023

 

Derek L. Graham

Chief Executive Officer

(Principal Executive Officer)

 


EXHIBIT 32.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

 

Pursuant to 18 U.S.C. Section 1350,

As adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

I, Narsi Narayanan, certify, to my best knowledge and belief, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of ClearOne, Inc. on Form 10-Q for the quarter ended March 31, 2023, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of ClearOne, Inc.

 

 

By:

/s/ Narsi Narayanan

May 15, 2023

 

Narsi Narayanan

Chief Financial Officer

(Principal Accounting and Principal Financial Officer)